Forecast: Diabetes Medicine Use in Belgium

The use of diabetes medicine in Belgium has shown a steady increase over the years, standing at 80.7 Units (Defined Daily Dosage) Per Thousand Persons Per Day (DDD/T/P/D) in 2023. From 2013 to 2023, the Compound Annual Growth Rate (CAGR) has averaged around 2.56%, with year-on-year variations ranging between minimal decreases and notable increases up to 4.12%. However, a slight deceleration is notable over more recent years with the five-year forecast CAGR predicted at 1.33%, pointing towards a projected use of 87.8 DDD/T/P/D by 2028.

For the future, trends to watch include advancements in diabetes treatment technology, potential changes in healthcare policies, and shifting demographics which may lead to variations in these forecasts. Monitoring these factors will be crucial in anticipating changes in medicine usage.